Public Reporting

Accountable Care Public Reporting Information

Accountable Care Organization (ACO) Name and Location

Freedom Healthcare Alliance, LLC
8761 Dorchester Road
Suite 230
North Charleston, SC 29420

ACO Primary Contact
Primary Contact Name: Lissa Lara, CEO
Primary Contact Phone Number: 843-412-1590
Primary Contact Email Address: lissalara@qualityhealthcaredevelopment.com

Organizational Information

ACO PARTICIPANTS ACO PARTICIPANT IN JOINT-VENTURE (Enter Y or N)
James T Martin Jr MD N
Liberty Doctors, LLC N
Dorchester Medical Associates N
Internal Medicine of Walterboro N
Lake City Family Medicine, LLC N

ACO Governing Body

Member First Name Member Last Name Title/Position Member’s Voting Power – Expressed as a percentage or number Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Lissa Lara CEO 16 Other N/A
Hugh Durrence MD CMO Board Member 13 ACO Participant Representative Liberty Doctors, LLC
Donald Hanna MD Board Member 13 ACO Participant Representative Liberty Doctors, LLC
Douglas Gleaton MD Board Member 13 ACO Participant Representative Liberty Doctors, LLC
John Forney MD Board Member 13 ACO Participant Representative Liberty Doctors, LLC
David Price MD Board Member 6 Medicare Beneficiary Representative N/A
James Martin Jr MD Board Member 13 ACO Participant Representative James T Martin Jr., LLC
Jeffrey  Kramer MD Board Member 13 ACO Participant Representative Internal Medicine of Walterboro

KEY ACO CLINICAL AND ADMINISTRATIVE LEADERSHIP:

Lissa Lara ACO Executive
Hugh Durrence Medical Director
John Park Compliance Officer
Katherine Hill Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Finance Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
Quality Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
Katherine Hill, Quality Assurance, Improvement Officer
Compliance Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
John Park, Compliance Officer

30Types of ACO participants, or combinations of participants, that formed the ACO:

  • Primary Care Physicians
  • Obstetrics and gynecology

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Second Agreement Period
    • Performance Year 2020, $2,960,193
  • First Agreement Period
    • Performance Year 2019, $921,888.92

 

Shared Savings Distribution:

  • Second Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%

    First Agreement Period

    • Performance Year 2019
      • Proportion invested in infrastructure: 37%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 53%

 

Quality Performance Results

2020 Quality Performance Results:

 

ACO Quality Measure Number

Measure Name

Rate

ACO Mean

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))

0.81

0.95

ACO-13

Falls: Screening for Future Fall Risk

81.27

84.97

ACO-14

Preventive Care and Screening: Influenza Immunization

66.13

76.03

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

76.47

81.67

ACO-18

Preventive Care and Screening: Screening for Depression and Follow-up Plan

66.67

71.46

ACO-19

Colorectal Cancer Screening

53.23

72.59

ACO-20

Breast Cancer Screening

60.53

74.05

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

79.62

83.37

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

13.38

14.70

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

70.94

72.87

 

“Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.”

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

 

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.